Anti-human FceR2 / CD23 (Lumiliximab Biosimilar) Beta chemokine receptor-like 1 The positive control slide provided

The positive control slide provided in the kit allows you to be sure that the experimental set-up is working properly

Regulation of desmin expression is stage and tissue-specific

These modifications include the covalent attachment of methyl or acetyl groups to lysine and arginine amino acids and the phosphorylation of serine or threonine

which plays an important role in cell-cell interactions

Binding of SCF by the c-Kit receptor leads to homodimerization of the receptor and the activation of signalling pathways such as PI-3

Anti-human FceR2 / CD23 (Lumiliximab Biosimilar) Beta chemokine receptor-like 1 The positive control slide providedApplication ELISA, Bioactivity: FACS, Functional assay, Research in vivo Reactivity Human Target Target Name FceR2 CD23 Target Uniprot P06734 Overview Catalog# BIO0588SM Product Name Anti human FceR2 CD23 (Lumiliximab Biosimilar) Specifications Conjugation None Clone# Lumiliximab Formulation 100 mM Pro Ac 20mM Arg pH 5. 0 Storage For long term storage, the produce should be stored at 20 or lower. Reconstitution Dissolve with sterile ddH2O